Company Filing History:
Years Active: 2022-2024
Title: **The Innovative Contributions of Loes Van Schie**
Introduction
Loes Van Schie is an accomplished inventor based in Ghent, Belgium, known for her significant contributions to the field of biotechnology. With two patents to her name, she has demonstrated a remarkable ability to innovate and address pressing medical challenges through her research.
Latest Patents
One of Loes Van Schie's latest patents focuses on the glycosylation of variable immunoglobulin domains. This invention provides nucleotide sequences encoding polypeptides comprising immunoglobulin variable domains with engineered glycosylation acceptor sites. The resultant immunoglobulin variable domain proteins are designed to be modified with selected glycans and specific glycan-conjugates, enhancing their functionality for various applications.
Another notable patent concerns compositions for treating cataracts. This invention presents a non-surgical method for treating cataracts in both humans and animals. It specifically pertains to the administration of a deglycating enzyme and its cofactors, which facilitate the deglycation of lens crystallins. This innovative approach offers a minimally invasive, cost-effective alternative to traditional surgical methods.
Career Highlights
Loes Van Schie has been associated with several prestigious organizations, including Vib Vzw and Universiteit Gent. Her work at these institutions has been instrumental in advancing research and developing beneficial biomedical innovations.
Collaborations
Throughout her career, Van Schie has collaborated with notable colleagues such as Nico Callewaert and Bram Laukens. These partnerships have enriched her research endeavors and led to impactful scientific advancements.
Conclusion
Loes Van Schie's innovative spirit is evident in her patents and collaborative efforts within the biomedical field. Her work continues to pave the way for novel treatments and underscores the importance of innovation in addressing health challenges. With her ongoing commitment to research, she is poised to make even greater contributions in the future.